We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
There were 167 varieties of Class 1 new drugs applied in China in the first half of this year, involving 129 pharmaceutical enterprises and research institutions.